Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.05 | -8.39 | -8.62 | 44.44% | CHEMBL140415 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.82 | -8.75 | N/A | 55.29% | CHEMBL41 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -7.97 | -7.80 | -8.03 | 54.64% | CHEMBL509446 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.64 | -9.06 | N/A | 62.50% | CHEMBL2022192 |
AA1R_HUMAN | adenosine A1 receptor | -8.14 | -7.70 | -8.05 | 34.91% | CHEMBL1544 |
AA2AR_HUMAN | adenosine A2a receptor | -8.50 | -8.57 | -8.35 | 31.78% | CHEMBL1795502 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.10 | -7.70 | -9.47 | 42.73% | CHEMBL87344 |
ACE_HUMAN | angiotensin I converting enzyme | -7.63 | -7.36 | -6.69 | 41.13% | CHEMBL254493 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.65 | N/A | N/A | 14.66% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -7.15 | -8.48 | -8.18 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -9.25 | -9.32 | N/A | 55.29% | CHEMBL41 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -9.03 | -8.07 | N/A | 42.86% | CHEMBL1346 |
ADRB2_HUMAN | adrenoceptor beta 2 | -7.84 | -9.13 | -8.71 | 47.83% | CHEMBL1940816 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -8.17 | -8.19 | -7.98 | 33.12% | CHEMBL34124 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.41 | -9.11 | -8.79 | 45.37% | CHEMBL312109 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.06 | -8.06 | -7.76 | 28.16% | CHEMBL3806197 |
AOFA_HUMAN | monoamine oxidase A | -8.52 | -8.47 | -9.17 | 47.96% | CHEMBL2391873 |
AOFB_HUMAN | monoamine oxidase B | -8.93 | -8.92 | -8.96 | 56.67% | CHEMBL1348198 |
BACE1_HUMAN | beta-secretase 1 | -6.34 | -6.97 | -7.51 | 57.41% | CHEMBL3745938 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.22 | -7.20 | -7.12 | 47.06% | CHEMBL3402967 |
CASP1_HUMAN | caspase 1 | -6.48 | -7.51 | -5.96 | 31.78% | CHEMBL115252 |
CDK5_HUMAN | cyclin dependent kinase 5 | -7.60 | -7.97 | -8.86 | 32.17% | CHEMBL2007296 |
CHLE_HUMAN | butyrylcholinesterase | -8.26 | -8.04 | -8.47 | 37.80% | CHEMBL369554 |
CNR1_HUMAN | cannabinoid receptor 1 | -8.16 | -8.45 | -9.16 | 51.95% | CHEMBL244607 |
CNR2_HUMAN | cannabinoid receptor 2 | -8.99 | -9.28 | N/A | 47.19% | CHEMBL3963126 |
COLI_HUMAN | proopiomelanocortin | -7.90 | -7.48 | -7.12 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.63 | -6.51 | -6.43 | 23.13% | CHEMBL3425731 |
CRP_HUMAN | C-reactive protein | -6.25 | -6.26 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -7.35 | N/A | N/A | 22.98% | CHEMBL376621 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.78 | -6.44 | -7.48 | 29.27% | CHEMBL4100900 |
DRD2_HUMAN | dopamine receptor D2 | -7.76 | N/A | N/A | 47.56% | CHEMBL334989 |
DRD3_HUMAN | dopamine receptor D3 | -7.74 | N/A | N/A | 47.56% | CHEMBL334989 |
DRD4_HUMAN | dopamine receptor D4 | -7.89 | -8.07 | N/A | 47.56% | CHEMBL334989 |
EDN1_HUMAN | endothelin 1 | -7.35 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -8.24 | -8.21 | -8.17 | 62.65% | CHEMBL234460 |
FABP5_HUMAN | fatty acid binding protein 5 | -7.56 | -5.49 | -5.22 | 49.49% | CHEMBL212860 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.26 | N/A | N/A | 37.37% | CHEMBL221753 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.47 | -8.25 | -8.21 | 13.00% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.99 | N/A | N/A | 13.00% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -9.40 | -9.87 | -9.54 | 56.67% | CHEMBL1348198 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.99 | -7.31 | -7.62 | 21.32% | CHEMBL3979391 |
HRH1_HUMAN | histamine receptor H1 | -10.76 | N/A | N/A | 51.35% | CHEMBL258930 |
HYES_HUMAN | epoxide hydrolase 2 | -7.64 | -8.13 | -7.79 | 42.00% | CHEMBL470363 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -7.55 | N/A | N/A | 36.73% | CHEMBL3318321 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -7.59 | -8.27 | N/A | 66.25% | CHEMBL272836 |
MIF_HUMAN | macrophage migration inhibitory factor | -8.09 | -7.62 | -7.97 | 27.38% | CHEMBL81201 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -7.32 | -6.90 | -7.31 | 38.30% | CHEMBL1909070 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -7.31 | -8.98 | -6.90 | 23.81% | CHEMBL2263390 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.58 | -8.55 | -8.44 | 26.86% | CHEMBL1091455 |
NEP_HUMAN | membrane metalloendopeptidase | -8.59 | -8.79 | -8.75 | 41.13% | CHEMBL254493 |
NK1R_HUMAN | tachykinin receptor 1 | -7.56 | -8.26 | -7.71 | 48.28% | CHEMBL93909 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.53 | -8.25 | -7.87 | 22.94% | CHEMBL284237 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.23 | -9.44 | -9.23 | 41.24% | CHEMBL48029 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.76 | -8.44 | -7.87 | 23.85% | CHEMBL419399 |
NOS1_HUMAN | nitric oxide synthase 1 | -8.61 | -8.72 | -7.94 | 37.19% | CHEMBL4081945 |
NOS2_HUMAN | nitric oxide synthase 2 | -7.20 | -8.32 | -8.29 | 50.51% | CHEMBL1762472 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.73 | -8.87 | -8.85 | 33.90% | CHEMBL261849 |
OPRD_HUMAN | opioid receptor delta 1 | -8.20 | -6.60 | -6.66 | 47.57% | CHEMBL431156 |
OPRK_HUMAN | opioid receptor kappa 1 | -8.63 | -8.96 | -8.94 | 46.90% | CHEMBL568309 |
OPRM_MOUSE | Mu-type opioid receptor | -8.72 | -7.43 | N/A | 46.23% | CHEMBL430441 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.28 | -7.37 | -7.32 | 42.42% | CHEMBL233493 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -5.57 | -5.21 | -5.27 | 28.32% | CHEMBL3958199 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.14 | -7.71 | -7.87 | 31.53% | CHEMBL91478 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -8.35 | N/A | N/A | 27.46% | CHEMBL3086083 |
PDE4B_HUMAN | phosphodiesterase 4B | -8.31 | -7.95 | -7.91 | 41.28% | CHEMBL1223618 |
PDE5A_HUMAN | phosphodiesterase 5A | -8.10 | -8.55 | -8.13 | 40.35% | CHEMBL362755 |
PERM_HUMAN | myeloperoxidase | -7.69 | -7.86 | -7.67 | 36.47% | CHEMBL3892909 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -7.87 | -8.60 | -8.17 | 53.41% | CHEMBL1958348 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -7.36 | -7.00 | -8.10 | 58.44% | CHEMBL1958349 |
PPAP_HUMAN | acid phosphatase 3 | -7.08 | N/A | N/A | 26.79% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -7.53 | -7.97 | -7.80 | 59.30% | CHEMBL592625 |
PRGR_HUMAN | progesterone receptor | -8.12 | -8.40 | -8.13 | 41.38% | CHEMBL511812 |
PTGES_HUMAN | prostaglandin E synthase | -6.67 | N/A | N/A | 68.13% | CHEMBL3754065 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -8.18 | -8.09 | -8.71 | 64.10% | CHEMBL641 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -8.70 | N/A | N/A | 44.09% | CHEMBL381488 |
TLR4_HUMAN | toll like receptor 4 | -7.75 | -7.65 | -7.80 | 30.00% | CHEMBL3261034 |
TNFA_HUMAN | tumor necrosis factor | -7.26 | N/A | N/A | 26.92% | CHEMBL72511 |
TRBM_HUMAN | thrombomodulin | -7.51 | -7.19 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.81 | -6.45 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -8.37 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.12 | N/A | N/A | 34.23% | CHEMBL2057858 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.21 | -7.86 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.21 | -7.56 | N/A | 29.23% | CHEMBL3692228 |
TRXR1_HUMAN | thioredoxin reductase 1 | -7.23 | -7.46 | -5.99 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.19 | N/A | N/A | 50.56% | CHEMBL320817 |